<p>Simulations Plus（纳斯达克股票代码：SLP - 获取免费报告）在周四更新了其 2026 财年的收益指引。该公司提供的每股收益（EPS）指引为 1.030-1.100，而市场共识 EPS 预期为 1.010。该公司发布的收入指引为 7900 万美元至 8200 万美元，而市场共识收入预期为 7960 万美元。</p>
<p>获取 <strong>Simulations Plus</strong> 的提醒：</p>
<h2>分析师评级变动</h2>
<ul>
<li>52 周低点？三只具有巨大上涨潜力的股票毫无问题</li>
</ul>
<p>多位分析师对 SLP 股票发表了看法。花旗集团在 10 月 28 日（星期二）的一份报告中重申了对 Simulations Plus 股票的 “市场表现” 评级。TD Cowen 在 9 月 30 日（星期二）的一份研究报告中开始覆盖 Simulations Plus 股票。他们对该股票给予了 “持有” 评级，目标价为 16.00 美元。KeyCorp 在 10 月 29 日（星期三）的一份研究报告中重申了对 Simulations Plus 股票的 “行业权重” 评级。Weiss Ratings 在 10 月 8 日（星期三）的一份研究报告中重申了对 Simulations Plus 股票的 “卖出（d-）” 评级。最后，Cowen 在 9 月 30 日（星期二）开始覆盖 Simulations Plus。他们对该股票设定了 “持有” 评级。一位投资分析师对该股票给予了强烈买入评级，四位给予了买入评级，五位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，该股票的平均评级为 “持有”，平均目标价为 24.40 美元。</p>
<p><strong>查看我们最新的 SLP 股票分析</strong></p>
<h2>Simulations Plus 价格表现</h2>
<ul>
<li>尽管每股收益超出预期，Simulations Plus 股票仍下跌 15%</li>
</ul>
<p>周四，纳斯达克 SLP 的股票开盘价为 19.80 美元。该股票的 50 日移动平均价格为 17.21 美元，200 日移动平均价格为 17.14 美元。Simulations Plus 的 1 年低点为 12.39 美元，1 年高点为 37.67 美元。该公司的市值为 3.9897 亿美元，市盈率为-6.15，贝塔值为 1.16。</p>
<p>Simulations Plus（纳斯达克股票代码：SLP - 获取免费报告）最后一次公布季度收益数据是在 12 月 1 日（星期一）。该科技公司报告的季度每股收益为 0.10 美元，符合分析师的共识预期 0.10 美元。Simulations Plus 的净利润率为-81.74%，股本回报率为 13.27%。该公司在本季度的收入为 1746 万美元，而市场共识预期为 1741 万美元。在去年同期，该公司每股收益为 0.06 美元。分析师预计 Simulations Plus 在当前财年将发布 1.09 的每股收益。</p>
<h2>对 Simulations Plus 的对冲基金看法</h2>
<ul>
<li>Simulations Plus：一只具有健康增长前景的医疗保健股票</li>
</ul>
<p>几家对冲基金和其他机构投资者最近买入和卖出了该公司的股票。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Simulations Plus 的持股增加了 4.3%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.现在拥有 9493 股该科技公司的股票，价值 23.3 万美元，此前在此期间又购买了 390 股。保诚金融公司在第二季度将其在 Simulations Plus 的持股增加了 5.7%。保诚金融公司现在拥有 17213 股该科技公司的股票，价值 30 万美元，此前在上个季度又购买了 930 股。景顺有限公司在第二季度将其在 Simulations Plus 的持股增加了 3.8%。景顺有限公司现在拥有 36452 股该科技公司的股票，价值 63.6 万美元，此前在上个季度又购买了 1323 股。雷蒙德·詹姆斯金融公司在第二季度收购了 Simulations Plus 的新股份，价值约 2.5 万美元。最后，US Bancorp DE 在第三季度将其在 Simulations Plus 的持股增加了 32.5%。US Bancorp DE 现在拥有 6167 股该科技公司的股票，价值 9.3 万美元，此前在上个季度又购买了 1513 股。78.08% 的股票由机构投资者和对冲基金持有。</p>
<h2>关于 Simulations Plus</h2>
<p>（获取免费报告）</p>
<p>Simulations Plus, Inc.开发药物发现和开发软件，用于建模和模拟，以及利用人工智能和机器学习技术预测分子特性。该公司通过软件和服务两个部门运营。它提供 GastroPlus，该软件模拟人类和动物对化合物的吸收和药物相互作用；以及 DDDPlus 和 MembranePlus 模拟产品。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票，而不是 Simulations Plus</li>
<li>纳斯达克证券交易所是什么？</li>
<li>市场动量：三只有望大幅突破的股票</li>
<li>恒生指数是什么？</li>
<li>Casey’s General Stores 将继续上涨的三个理由</li>
<li>股票市场升级：它们是什么？</li>
<li>黄金交叉警报：三只具有重大上涨潜力的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0xQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0xQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Simulations Plus 吗？</h2>
<p>在你考虑 Simulations Plus 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Simulations Plus 并不在名单上。</p>
<p>虽然 Simulations Plus 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Simulations Plus（纳斯达克代码：SLP）更新了其 2026 财年的盈利指引，预计每股收益（EPS）为 1.030-1.100，高于市场共识预期的 1.010。收入指引设定在 7900 万美元至 8200 万美元之间，而市场共识为 7960 万美元。分析师对 SLP 的评级不一，平均评级为 “持有”，目标价为 24.40 美元。该股票开盘价为 19.80 美元，市值为 3.9897 亿美元。机构投资者持有该股票的 78.08%</p>

<p>Simulations Plus (NASDAQ:SLP - Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 1.030-1.100 for the period, compared to the consensus EPS estimate of 1.010. The company issued revenue guidance of $79.0 million-$82.0 million, compared to the consensus revenue estimate of $79.6 million.</p>
<div class="lb-trans"><p>Simulations Plus（纳斯达克股票代码：SLP - 获取免费报告）在周四更新了其 2026 财年的收益指引。该公司提供的每股收益（EPS）指引为 1.030-1.100，而市场共识 EPS 预期为 1.010。该公司发布的收入指引为 7900 万美元至 8200 万美元，而市场共识收入预期为 7960 万美元。</p>
</div><p>Get <strong>Simulations Plus</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Simulations Plus</strong> 的提醒：</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><ul>
<li>52-Week Lows? No Problem for 3 Stocks With Big Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>52 周低点？三只具有巨大上涨潜力的股票毫无问题</li>
</ul>
</div><p>A number of analysts have weighed in on SLP shares. Citigroup reissued a &#34;market perform&#34; rating on shares of Simulations Plus in a report on Tuesday, October 28th. TD Cowen initiated coverage on shares of Simulations Plus in a research report on Tuesday, September 30th. They issued a &#34;hold&#34; rating and a $16.00 target price on the stock. KeyCorp reissued a &#34;sector weight&#34; rating on shares of Simulations Plus in a research report on Wednesday, October 29th. Weiss Ratings restated a &#34;sell (d-)&#34; rating on shares of Simulations Plus in a research note on Wednesday, October 8th. Finally, Cowen began coverage on Simulations Plus in a research report on Tuesday, September 30th. They set a &#34;hold&#34; rating on the stock. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of &#34;Hold&#34; and an average target price of $24.40.</p>
<div class="lb-trans"><p>多位分析师对 SLP 股票发表了看法。花旗集团在 10 月 28 日（星期二）的一份报告中重申了对 Simulations Plus 股票的 “市场表现” 评级。TD Cowen 在 9 月 30 日（星期二）的一份研究报告中开始覆盖 Simulations Plus 股票。他们对该股票给予了 “持有” 评级，目标价为 16.00 美元。KeyCorp 在 10 月 29 日（星期三）的一份研究报告中重申了对 Simulations Plus 股票的 “行业权重” 评级。Weiss Ratings 在 10 月 8 日（星期三）的一份研究报告中重申了对 Simulations Plus 股票的 “卖出（d-）” 评级。最后，Cowen 在 9 月 30 日（星期二）开始覆盖 Simulations Plus。他们对该股票设定了 “持有” 评级。一位投资分析师对该股票给予了强烈买入评级，四位给予了买入评级，五位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，该股票的平均评级为 “持有”，平均目标价为 24.40 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on SLP</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 SLP 股票分析</strong></p>
</div><h2>Simulations Plus Price Performance</h2>
<div class="lb-trans"><h2>Simulations Plus 价格表现</h2>
</div><ul>
<li>Simulations Plus Stock Drops 15% Despite EPS Beat</li>
</ul>
<div class="lb-trans"><ul>
<li>尽管每股收益超出预期，Simulations Plus 股票仍下跌 15%</li>
</ul>
</div><p>Shares of NASDAQ SLP opened at $19.80 on Thursday. The stock has a fifty day moving average price of $17.21 and a 200 day moving average price of $17.14. Simulations Plus has a 1-year low of $12.39 and a 1-year high of $37.67. The company has a market cap of $398.97 million, a PE ratio of -6.15 and a beta of 1.16.</p>
<div class="lb-trans"><p>周四，纳斯达克 SLP 的股票开盘价为 19.80 美元。该股票的 50 日移动平均价格为 17.21 美元，200 日移动平均价格为 17.14 美元。Simulations Plus 的 1 年低点为 12.39 美元，1 年高点为 37.67 美元。该公司的市值为 3.9897 亿美元，市盈率为-6.15，贝塔值为 1.16。</p>
</div><p>Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its quarterly earnings data on Monday, December 1st. The technology company reported $0.10 EPS for the quarter, hitting analysts' consensus estimates of $0.10. Simulations Plus had a negative net margin of 81.74% and a positive return on equity of 13.27%. The company had revenue of $17.46 million during the quarter, compared to the consensus estimate of $17.41 million. During the same quarter in the prior year, the firm earned $0.06 EPS. Analysts anticipate that Simulations Plus will post 1.09 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Simulations Plus（纳斯达克股票代码：SLP - 获取免费报告）最后一次公布季度收益数据是在 12 月 1 日（星期一）。该科技公司报告的季度每股收益为 0.10 美元，符合分析师的共识预期 0.10 美元。Simulations Plus 的净利润率为-81.74%，股本回报率为 13.27%。该公司在本季度的收入为 1746 万美元，而市场共识预期为 1741 万美元。在去年同期，该公司每股收益为 0.06 美元。分析师预计 Simulations Plus 在当前财年将发布 1.09 的每股收益。</p>
</div><h2>Hedge Funds Weigh In On Simulations Plus</h2>
<div class="lb-trans"><h2>对 Simulations Plus 的对冲基金看法</h2>
</div><ul>
<li>Simulations Plus: A Health Care Stock with Healthy Growth Prospects</li>
</ul>
<div class="lb-trans"><ul>
<li>Simulations Plus：一只具有健康增长前景的医疗保健股票</li>
</ul>
</div><p>Several hedge funds and other institutional investors have recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Simulations Plus by 4.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company's stock valued at $233,000 after purchasing an additional 390 shares during the period. Prudential Financial Inc. boosted its holdings in shares of Simulations Plus by 5.7% during the 2nd quarter. Prudential Financial Inc. now owns 17,213 shares of the technology company's stock worth $300,000 after buying an additional 930 shares in the last quarter. Invesco Ltd. boosted its holdings in shares of Simulations Plus by 3.8% during the 2nd quarter. Invesco Ltd. now owns 36,452 shares of the technology company's stock worth $636,000 after buying an additional 1,323 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Simulations Plus during the 2nd quarter worth approximately $25,000. Finally, US Bancorp DE increased its stake in shares of Simulations Plus by 32.5% in the 3rd quarter. US Bancorp DE now owns 6,167 shares of the technology company's stock valued at $93,000 after acquiring an additional 1,513 shares in the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>几家对冲基金和其他机构投资者最近买入和卖出了该公司的股票。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Simulations Plus 的持股增加了 4.3%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.现在拥有 9493 股该科技公司的股票，价值 23.3 万美元，此前在此期间又购买了 390 股。保诚金融公司在第二季度将其在 Simulations Plus 的持股增加了 5.7%。保诚金融公司现在拥有 17213 股该科技公司的股票，价值 30 万美元，此前在上个季度又购买了 930 股。景顺有限公司在第二季度将其在 Simulations Plus 的持股增加了 3.8%。景顺有限公司现在拥有 36452 股该科技公司的股票，价值 63.6 万美元，此前在上个季度又购买了 1323 股。雷蒙德·詹姆斯金融公司在第二季度收购了 Simulations Plus 的新股份，价值约 2.5 万美元。最后，US Bancorp DE 在第三季度将其在 Simulations Plus 的持股增加了 32.5%。US Bancorp DE 现在拥有 6167 股该科技公司的股票，价值 9.3 万美元，此前在上个季度又购买了 1513 股。78.08% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>About Simulations Plus</h2>
<div class="lb-trans"><h2>关于 Simulations Plus</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.</p>
<div class="lb-trans"><p>Simulations Plus, Inc.开发药物发现和开发软件，用于建模和模拟，以及利用人工智能和机器学习技术预测分子特性。该公司通过软件和服务两个部门运营。它提供 GastroPlus，该软件模拟人类和动物对化合物的吸收和药物相互作用；以及 DDDPlus 和 MembranePlus 模拟产品。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Simulations Plus</li>
<li>What is the NASDAQ Stock Exchange?</li>
<li>Market Momentum: 3 Stocks Poised for Major Breakouts</li>
<li>What is the Hang Seng index?</li>
<li>3 Reasons Casey’s General Stores Will Continue Trending Higher</li>
<li>Stock Market Upgrades: What Are They?</li>
<li>Golden Cross Alert: 3 Stocks With Major Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，而不是 Simulations Plus</li>
<li>纳斯达克证券交易所是什么？</li>
<li>市场动量：三只有望大幅突破的股票</li>
<li>恒生指数是什么？</li>
<li>Casey’s General Stores 将继续上涨的三个理由</li>
<li>股票市场升级：它们是什么？</li>
<li>黄金交叉警报：三只具有重大上涨潜力的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0xQ" alt="" original-src="https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx?Prefix=NASDAQ&amp;Symbol=SLP"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Simulations Plus Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Simulations Plus 吗？</h2>
</div><p>Before you consider Simulations Plus, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Simulations Plus 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Simulations Plus 并不在名单上。</p>
</div><p>While Simulations Plus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Simulations Plus 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Simulations Plus（NASDAQ:SLP）更新了 2026 财年的收益指引